ATOSSA THERAPEUTICS INC. - COMMON STOCK
1.5000
24-أبريل-24 15:59:59
15 متأخرة بدقائق
الأسهم
+0.0100
+0.67%
نطاق اليوم
1.4800 - 1.5950
ISIN
N/A
المصدر
NASDAQ
-
15 أبريل 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
11 أبريل 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
09 أبريل 2024 11:59:00 بحسب Nasdaq GlobeNewswire
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
05 أبريل 2024 09:58:53 بحسب NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
04 أبريل 2024 11:38:29 بحسب NetDania Notify
-
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
01 أبريل 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
01 أبريل 2024 12:27:21 بحسب NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
28 مارس 2024 10:08:00 بحسب NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
26 مارس 2024 09:45:03 بحسب NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
25 مارس 2024 10:40:51 بحسب NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
20 مارس 2024 09:45:01 بحسب NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
19 مارس 2024 10:49:14 بحسب NetDania Notify
-
19 مارس 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
18 مارس 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
12 مارس 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
06 مارس 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
22 فبراير 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
07 فبراير 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Atossa Therapeutics Issues Letter to Shareholders
09 يناير 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
04 ديسمبر 2023 08:30:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >